Microbiome News and Research

Latest Microbiome News and Research

A promising treatment for chronic inflammatory liver disease

Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat.

14 May 2020

Scientists are looking for alternate methods to predict the spread of COVID-19

With the ongoing challenges associated with large-scale testing for COVID-19--including test kit shortages, stringent testing criteria and the inherent limitations of current tracking systems on mildly symptomatic and asymptomatic populations, scientists are looking for alternate methods to boost testing in order to predict the spread of the disease.

13 May 2020

A 'multi-omics' approach to the development of drugs against COVID-19

A new study published on the preprint server medRxiv* in May 2020 reports a multi-omics approach that could make it easier to develop drugs that are effective against COVID-19.

12 May 2020

Microbiome controls the fitness of our immune system

Working alongside colleagues in Mainz, Bern, Hannover and Bonn, researchers from Charité - Universitätsmedizin Berlin, the Berlin Institute of Health and the German Rheumatism Research Center Berlin were able to show how the microbiome helps to render the immune system capable of responding to pathogens.

11 May 2020

Lab Automation for Biome Research

News Medical Life Sciences discussed how lab automation can improve the efficiency of biome research with Tom Copeland, Sales and Marketing Coordinator of Hudson Robotics, at Pittcon 2020.

From Hudson Robotics 11 May 2020

Combination therapy trial to understand the biology, spread, treatment of COVID-19

The HonorHealth Research Institute and HonorHealth announced today the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection.

6 May 2020

The Role of Microphysiological Systems for Oncology and Stem Cell Research

In this interview, Dr. Nancy Allbritton from The Allbritton Lab talks to News-Medical and Life Sciences about the revolutionary technology and techniques for the application of new technologies for oncology and stem cell research.

From Pittcon 6 May 2020

Human to Labskin Skin Models for Dermatology Research

A Human Skin Equivalent (HSE) skin model used for dermatology research, made from the same primary human cells but grown to a defined specification in a laboratory and not as complex as Human skin, lacking hair follicles and immune cells.

6 May 2020

New computer modeling systems to predict spread of SARS-CoV-2 virus

Joe Mihaljevic, mathematical epidemiologist and assistant professor in Northern Arizona University's School of Informatics, Computing, and Cyber Systems, is leading a new project to create computer modeling systems to predict outcomes of the spread of the SARS-CoV-2 virus, which causes COVID-19, across four northern Arizona counties--Coconino, Navajo, Apache and Mohave.

4 May 2020

Viruses from stool can help fight obesity and type 2 diabetes

Obese mice with unhealthy lifestyles gain significantly less weight and avoid type 2 diabetes when they receive viruses transplanted from the stool of lean mice. These are the findings of a new University of Copenhagen study.

4 May 2020

Changes to gut microbiome could improve cancer outcomes for smokers

Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week 2020.

30 Apr 2020

Study explores molecular connections between genetics, gut microbiome and memory

A new study is among the first to trace the molecular connections between genetics, the gut microbiome and memory in a mouse model bred to resemble the diversity of the human population.

29 Apr 2020

Study with twins shows COVID-19 symptoms have genetic contribution

A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.

29 Apr 2020

New nasopharyngeal swabs move into human trials for COVID-19

Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.

28 Apr 2020

Gut microbiome influences pattern of activation in rat’s brain during opioid addiction

When Sierra Simpson was in college, she was sick for a year with recurring fevers and vomiting. Her doctors couldn't figure out what she had. Suspecting a bacterial infection, they tried treating her with high doses of antibiotics.

27 Apr 2020

Gut microbiota could predict severity of COVID-19

The COVID-19 pandemic is spreading to every corner of the world. But not everyone is falling sick at the same rate. A new study published on the preprint server medRxiv in April 2020 suggests that the composition of the gut microbiome could partially explain the difference in susceptibility. This adds a new dimension to what is currently known about the disease.

27 Apr 2020

Research on sweet potato microbiome is a major step for enhancing yield

Grown around the world, sweet potatoes are an important source of nutrition particularly in sub-Saharan African and Asian diets. Sweet potatoes are especially significant to sub-Saharan Africa as a source of Vitamin A, a nutrient commonly deficient in the region.

23 Apr 2020

Antibiotics linked to increased risk of opioid abuse

Taking antibiotics alongside opioids may increase the risk of opioid abuse, according to research in rats recently published in eNeuro.

22 Apr 2020

Restrictive healthcare policies may delay diagnosis and treatment of tuberculosis

The introduction of policies that restrict healthcare access for visitors and migrants not entitled to free NHS care may be associated with delays in diagnosis and treatment for patients with tuberculosis (TB) who were not born in the UK, according to a study published in the open access journal BMC Public Health.

20 Apr 2020

Study shows how interactions between microbiome and the immune system contribute to liver disease

A new study by researchers in the Quadram Institute has provided insights into how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease.

20 Apr 2020